GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Ltd Board to Consider Q1 FY27 Results, Capital Increase, NCRPS Issue

RESULTS ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 06 Aug 2026, 12:37 PM IST  ·  BSE ID: 8c5207de-89eb-4055-90f9-8c28641f5a09
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet to review its latest financial results, consider raising capital, and discuss its annual general meeting plans.
🤖 AI Summary
  • Chemiesynth (Vapi) Ltd Board of Directors to meet on August 12, 2026, at 3:00 PM.
  • Board to consider unaudited financial results for the quarter ended June 30, 2026, with a limited review report.
  • Agenda includes proposing an increase in Authorized Share Capital and amending Memorandum and Articles of Association.
  • Board will also propose offering and issuing unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on private placement.
  • Other items include fixing the 40th Annual General Meeting details and approving related party transactions.
🏢 How This Affects the Company
📈
Business Impact
The potential increase in authorized share capital and the issue of NCRPS could provide funding for future business growth or operational needs, depending on the utilization of the raised capital.
💰
Financial Impact
If approved, the NCRPS issue will alter the company's capital structure by introducing preference shares, impacting equity and potential future dividend obligations for these shares.
⚠️
Risk Impact
Proposing an increase in authorized share capital and issuing NCRPS via private placement introduces financing activity, whose terms will determine any associated financial risks for the company.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take immediate action based on this intimation of a Board Meeting.
👤
Who Is Affected
Existing shareholders may be affected by the proposed increase in Authorized Share Capital and the issue of NCRPS, which could impact future capital structure and voting rights if the MOA/AOA amendments involve such changes.
🔍
Management Signal
The management's decision to consider a capital increase and NCRPS issue signals a proactive approach to potential funding requirements or capital restructuring for the company.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Board Meeting Outcome on August 12, 2026 — details of Q1 FY27 financial results.
Board Meeting Outcome on August 12, 2026 — specific terms and size of proposed NCRPS issue.
Board Meeting Outcome on August 12, 2026 — details of the increase in Authorized Share Capital.
MEDIUM RISK Proposals for capital increase and NCRPS issue carry inherent financial and structural risks, details of which are not yet public.
💡 Investor Takeaway
Chemiesynth (Vapi) Ltd Board will meet on August 12, 2026, to consider Q1 FY27 unaudited financial results and evaluate proposals for increasing authorized share capital and issuing Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) via private placement. The 40th Annual General Meeting details will also be finalized.
⚖️ Strengths & Concerns

✅ Positives

  • The company is proactively addressing capital structure needs by proposing an increase in Authorized Share Capital.
  • Plans to raise funds through Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) could strengthen financial liquidity.
❓ Frequently Asked Questions
When is the Board Meeting of Chemiesynth (Vapi) Ltd scheduled?
The meeting of the Board of Directors of Chemiesynth (Vapi) Ltd is scheduled for Wednesday, August 12, 2026, at 3:00 PM.
What financial results will the Board of Chemiesynth (Vapi) Ltd consider?
The Board will consider the Un-audited Financial Results of Chemiesynth (Vapi) Ltd for the Quarter ended June 30th, 2026, along with the Limited Review Report.
What capital-related proposals will the Board of Chemiesynth (Vapi) Ltd discuss?
The Board will discuss proposing an increase in Authorized Share Capital and the offer, issue, and allotment of Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a Private Placement basis.
What is the purpose of closing the trading window for Chemiesynth (Vapi) Ltd?
The trading window for Chemiesynth (Vapi) Ltd was closed from Wednesday, July 01, 2026, in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015, and will reopen 48 hours after the declaration of results.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.